Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agilysys Inc (AGYS) vs Heron Therapeutics Inc (HRTX) Price & Performance

Agilysys IncTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Agilysys Inc vs Heron Therapeutics Inc — how do they compare? Agilysys Inc trades at $104.22 (market cap $3.00B), while Heron Therapeutics Inc trades at $0.33 (market cap $61.47M). The key difference: Agilysys Inc is far larger — about 48.8× Heron Therapeutics Inc's market cap, and Agilysys Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

AGYSHRTX
Market Cap
$3.00B$61.47M
Sector
TechnologyHealth
52-Week High
$141.12$1.49
52-Week Low
$62.19$0.32
Enterprise Value
$2.90B$168.21M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Agilysys Inc

No Aura AI signal available yet.

Heron Therapeutics Inc

HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.

The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Agilysys Inc

Agilysys provides enterprise software and SaaS solutions for the hospitality industry. Its products specialize in point-of-sale, property management, and inventory systems for hotels, resorts, and cruise lines.

Read more on AGYS

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX